Results 161 to 170 of about 1,086,509 (221)
Some of the next articles are maybe not open access.
Injectable contraception: updates and innovation
Current Opinion in Obstetrics & Gynecology, 2016Purpose of review Injectable contraception is a highly effective form of birth control that is globally popular. Recent research has focused on ways to make injectables such as depot medroxyprogesterone acetate (DMPA) more accessible and to improve the side-effect profile of injectables. This review will focus on new directions
Gillian, Schivone +2 more
openaire +3 more sources
Injectable contraception: issues and opportunities
Contraception, 2014Beginning in the 1960s depot medroxyprogesterone acetate (DMPA) injectable contraception has been widely used in family planning programs abroad especially in Africa and Southeast Asia [1]. Approved in the US for the treatment of endometrial cancer in the mid-1960s it was also used off-label for contraception [2].
Andrew M, Kaunitz +2 more
openaire +3 more sources
Long-Acting Injectable Contraception With Depot Medroxyprogesterone Acetate
American Journal of Obstetrics and Gynecology, 1994Rubymel Jijon Knupp
exaly +4 more sources
International journal of pharmaceutics, 2022
The integration of mechanistic modeling and machine learning facilitates the understanding and engineering of drug release from controlled release systems.
Sowmya Sivasankaran, S. Jonnalagadda
semanticscholar +1 more source
The integration of mechanistic modeling and machine learning facilitates the understanding and engineering of drug release from controlled release systems.
Sowmya Sivasankaran, S. Jonnalagadda
semanticscholar +1 more source
Injectable in Situ Forming Depot Systems for Long-Acting Contraception
Advanced Biology, 2017Suryatheja Ananthula +2 more
exaly +2 more sources
The Lancet HIV, 2015 Data from the VOICE study1 showing greater HIV-1 acquisition among women who use depot medroxyprogersterone acetate (DMPA) than injectable norethisterone (NET-EN) contraception elicited comment suggesting that use of DMPA be limited.2 The fundamental ...
G. Hofmeyr +3 more
semanticscholar +2 more sources
Clinical Obstetrics & Gynecology, 2007
Injectable contraceptive methods are safe, highly efficacious, and commonly used worldwide. Depo-Provera (depot-medroxyprogesterone acetate) is the most commonly used injectable in the United States. It is a convenient, discrete, and low-maintenance method, and is ideal for patients with contraindications to estrogen use and certain medical conditions.
Sadia, Haider, Philip D, Darney
openaire +2 more sources
Injectable contraceptive methods are safe, highly efficacious, and commonly used worldwide. Depo-Provera (depot-medroxyprogesterone acetate) is the most commonly used injectable in the United States. It is a convenient, discrete, and low-maintenance method, and is ideal for patients with contraindications to estrogen use and certain medical conditions.
Sadia, Haider, Philip D, Darney
openaire +2 more sources
Evidence-Based Guidance for Self-Administration of Injectable Contraception.
Journal of midwifery & women's health, 2020The requirement of in-person visits every 3 months for a health care provider to administer intramuscular depot medroxyprogesterone acetate (DMPA-IM) is a significant barrier to its use, particularly in the wake of the coronavirus pandemic.
M. Marx
semanticscholar +1 more source
Injectable Contraception: New and Existing Options
Obstetrics and Gynecology Clinics of North America, 2000Rubymel Jijon Knupp, A M Kaunitz
exaly +2 more sources
Injectable contraception: emerging evidence on subcutaneous self-administration.
Current Opinion in Obstetrics and Gynecology, 2019PURPOSE OF REVIEW Injectable contraception is a widely available and popular family planning method globally. It has evolved to allow for subcutaneous self-injection (DMPA-SC, Depo medroxyprogesterone acetate-subcutaneous).
K. Lerma, Lisa M Goldthwaite
semanticscholar +1 more source